logo-loader
viewReckitt Benckiser

Reckitt Benckiser plunges as US investment bank slams ‘weak’ work culture

“The surprise retirement of CEO Kapoor crystallises long-brewing anxieties. We see no quick fixes and a material risk of a margin re-set under a new CEO.”

strepsils
Sales of RB’s cold and flu products in the US are likely to fall this year

Reckitt Benckiser Group PLC (LON:RB.) was among the top blue-chip losers on Thursday after US investment bank Jefferies downgraded its rating of the consumer goods giant.

Analysts are concerned that the weak cold and flu season in the season could hit sales of some of Reckitt’s big brands such as Strepsils, Lemsip and Nurofen.

Those worries knocked 4% off the share price on Wednesday, and Jefferies thinks there is “still further to go”.

READ: Reckitt boss to step down this year

But the analysts’ biggest issue is with the workplace culture, especially after the “surprise retirement” of chief executive Rakesh Kapoor who is due to leave by the end of the year.

“The surprise retirement of CEO Rakesh Kapoor crystallises long-brewing anxieties around RB's predicament,” read a note to clients.

“There are strong runners and riders for the role aplenty. But this is a challenge

beyond mere fresh legs. The unique RB pay for performance model, so powerful for so long, is now under pressure, laying bare the fact that RB has the weakest culture and workstyle ratings in the peer group.”

The analysts argue that the merger of GlaxoSmithKline PLC’s (LON:GSK) and Pfizer’s consumer health businesses – Reckitt was interested in Pfizer’s assets – might have been “the straw that broke Kapoor’s back”.

“Not only does it stalemate RB strategically, it also cuts off a vital source of fresh innovation. That leaves RB's Health Relief portfolio reliant on under-pressure Mucinex and a yeoman infantry of Nurofen, Strepsils and Gaviscon fast running out of marching space.”

Given its various fears, Jefferies has downgraded the FTSE 100 group to ‘underperform’ from hold, while it has also slashed its price target to 5,000p from 6,800p previously.

Reckitt shares fell 3% on Thursday morning to 5,611p, making it the biggest faller on London’s blue-chip index.

Quick facts: Reckitt Benckiser

Price: 5983 GBX

LSE:RB.
Market: LSE
Market Cap: £42.47 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: Block Energy completes critical phase of WR-38Z sidetrack

Headlines from Proactive UK newsroom. Block Energy (LON:BLOE) has completed a critical phase of the sidetrack programme at its WR-38Z well on the West Rustavi field in Georgia. New casing has been cemented through the build section of the well, which will prevent fluid incursion into the...

6 minutes ago

2 min read